Multidimensional analysis of anxiety symptoms in patients with chronic obstructive pulmonary disease (COPD)

To explore the potential classes of anxiety symptoms in patients with chronic obstructive pulmonary disease (COPD) and analyze their distinct characteristics. Convenience sampling was used to select 211 cases of COPD from 12 hospitals in Hebei Province. The following scales were used: General Inform...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 15; no. 1; pp. 11356 - 9
Main Authors Wang, Li’ao, Miao, Dong, Wang, Meiying, He, Gang, Li, Zhengqiao, Hou, Yunsheng, Zhang, Lei
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 02.04.2025
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To explore the potential classes of anxiety symptoms in patients with chronic obstructive pulmonary disease (COPD) and analyze their distinct characteristics. Convenience sampling was used to select 211 cases of COPD from 12 hospitals in Hebei Province. The following scales were used: General Information Questionnaire, Anxiety Inventory for Respiratory Disease (AIR), BODE index, Montreal Cognitive Assessment (MoCA), and SF-36 Quality of Life scale. Latent profile analysis (LPA) was conducted on the anxiety symptoms of the survey subjects, and univariate analysis and ordinal logistic regression were used to analyze the risk factors of different profiles. Anxiety symptoms among COPD patients were classified into three types: low-risk anxiety type (57.8%), moderate anxiety-fear type (23.2%), and high anxiety-fear type (19.0%). Ordered multinomial logistic regression analysis revealed that the duration of disease, BODE index, MoCA scores, and SF-36 scores were identified as independent risk factors for the potential classes of anxiety symptoms in COPD patients ( p  < 0.05). There is heterogeneity in anxiety symptoms among COPD patients. Medical staff can provide targeted interventions based on the characteristics and risk factors of different populations to alleviate anxiety symptoms.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-025-96007-5